USANA Health Sciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
USANA Health Sciences (USNA) Tops Q2 EPS by 24c, Revenues Beat; Raises FY20 EPS/Revenue Outlook
July 21, 2020 4:19 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.32, $0.24 better than the analyst estimate of $1.08. Revenue for the quarter came in at $259 million versus the consensus estimate of $256.33 million.
Key Financial & Operating Highlights
Continued strong demand and successful promotions combined to generate $259.0 million in net sales and $1.32 in diluted EPS during the quarterActive customers increased 7.9% vs. the prior-year quarterCompany continued to successfully execute a virtual sales and operating strategy to deliver resultsCompany raises full-year 2020 Net Sales and EPS outlookStrong consumer demand for our high-quality, health products and... More
